Cited in | Search | Type: | Patent literature | Publication No.: | WO2004085401
[X] (PFIZER PROD INC [US], et al) [X] 1-15 * page 80 - page 81; examples 170-409; claims 1, 5, 10 *; | Type: | Patent literature | Publication No.: | WO2011054848
[A] (GLAXOSMITHKLINE LLC [US], et al) [A] 1-15* claims 1, 25, 32 * | Cited in | International search | Type: | Patent literature | Publication No.: | US7101869
[A] (BLUMENKOPF TODD A [US], et al); | Type: | Patent literature | Publication No.: | US2010179325
[A] (SUZUKI RYO [JP], et al); | Type: | Patent literature | Publication No.: | US2010267672
[A] (JUNG KYUNG-YUN [KR], et al) | Cited in | by applicant | Type: | Patent literature | Publication No.: | US5262564
| Type: | Patent literature | Publication No.: | WO2004085401
| Type: | Patent literature | Publication No.: | WO2011054848
| Type: | Non-patent literature | Publication information: | - MULLER, S.; FILIPPAKOPOULOS, P.; KNAPP, S., "Bromodomains as therapeutic targets", Expert Rev. Mol. Med., (20110000), vol. 13, doi:doi:10.1017/s1462399411001992, page e29, XP002670944 | DOI: | http://dx.doi.org/10.1017/s1462399411001992 | Type: | Non-patent literature | Publication information: | - NICODEME et al., Nature, (20100000), vol. 468, page 1119 | Type: | Non-patent literature | Publication information: | - DHALLUIN C.; CARLSON J.E.; ZENG L.; HE C.; AGGARWAL A.K.; ZHOU M.M., "Structure and ligand of a histone acetyltransferase bromodomain", Nature, (19990000), vol. 399, pages 491 - 6 | Type: | Non-patent literature | Publication information: | - CRAWFORD, N.P; ALSARRAJ, J.; LUKES, L.; WALKER, R.C.; OFFICEWALA, J.S.; YANG, H.H.; LEE, M.P.; OZATO, K.; HUNTER, K.W., "Bromodomain 4 Activation Predicts Breast Cancer Survival", Proc. Natl. Acad. Sci. USA., (20080000), vol. 105, no. 17, pages 6380 - 6385 | Type: | Non-patent literature | Publication information: | - GUO, N.; FALLER, D.V.; DENIS, G.V., "Activation-Induced Nuclear Translocation of RING3", J. Cell Sci., (20010000), vol. 113, no. 17, pages 3085 - 3091 | Type: | Non-patent literature | Publication information: | - DELMORE J.E.; ISSA G.C.; LEMIEUX M.E.; RAHL, P.B.; SHI J.; JACOBS H.M., "BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc", Cell, (20110000), vol. 146, doi:doi:10.1016/j.cell.2011.08.017, pages 904 - 17, XP028295705 | DOI: | http://dx.doi.org/10.1016/j.cell.2011.08.017 | Type: | Non-patent literature | Publication information: | - DAWSON, M. A; PRINJHA, R.K.; DITTMAN, A.; GIOTOPOULOS, G.; BANTCHEFF, M.; CHAN, W-I.; ROBSON, S.C.; CHUNG, C.; HOPF, C.; SAVITSKI,, "Inhibition of BET recruitment of chromatin as an effective treatment of MLL-fusion leukemia", Nature, (20110000), vol. 0, pages 1 - 5 | Type: | Non-patent literature | Publication information: | - PICAUD, S.; DA COSTA, D.; THANASOPOULOU, A.; FILIPPAKOPOULOS, P.; FISH, P.; PHILPOTT, M.; FEDEROV, O.; BRENNAN, P.; BUNNAGE, M. E., "PFI-1 - A highly Selective Protein Interaction Inhibitor Targeting BET Bromodomains", Cancer Res., (20130000), vol. 73, no. 11, doi:doi:10.1158/0008-5472.CAN-12-3292, pages 3336 - 3346, XP055130754 | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-12-3292 | Type: | Non-patent literature | Publication information: | - S. BERGE et al., Journal of Pharmaceutical Sciences, (19770000), vol. 66, no. 1, pages 1 - 19 | Type: | Non-patent literature | Publication information: | - P. GOULD, International J. of Pharmaceutics, (19860000), vol. 33, pages 201 - 217 | Type: | Non-patent literature | Publication information: | - The Orange Book, Food & Drug Administration |